Dr Naheed Alam, | |
617 Central Ave, Dunkirk, NY 14048-2529 | |
(716) 366-1223 | |
(716) 366-6844 |
Full Name | Dr Naheed Alam |
---|---|
Gender | Female |
Speciality | Hematology/oncology |
Experience | 25 Years |
Location | 617 Central Ave, Dunkirk, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255592168 | NPI | - | NPPES |
04243569 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 280648 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Erie County Medical Center | Buffalo, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Erie County Medical Center Corporation | 1456308907 | 207 |
News Archive
Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period. A two-year study compared the use of disinfection caps to an intense scrub-the-hub intervention to standard care. Scrub-the-hub refers to cleaning catheter connector hubs and injection ports with alcohol for the recommended 15 seconds before accessing the central line, a catheter placed in a large vein to deliver medicine and liquids during hospitalization.
inVentiv Commercial, a division of inVentiv Health and the industry leader in outsourced sales teams to the pharmaceutical industry, announced today that it has been selected by international specialty pharmaceuticals company BTG International Inc to provide a sales team, as well as training and fulfillment services, for the company's CroFab® and DigiFab® products.
The number of Americans who report they have coronary heart disease – which includes heart attack and angina (chest pain) – continues to decline but rates vary widely from state to state and by race and ethnicity, according to a new report published today in the Morbidity and Mortality Weekly Report of the Centers for Disease Control and Prevention.
A CSIRO innovation for determining gene function quickly and with virtually 100 per cent efficiency has been granted a US patent clarifying its leadership position in the international gene silencing arena.
Decision Resources Group finds that the market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
› Verified 7 days ago
Entity Name | Cogent Medical Care Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912941238 PECOS PAC ID: 7315836780 Enrollment ID: O20040312001215 |
News Archive
Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period. A two-year study compared the use of disinfection caps to an intense scrub-the-hub intervention to standard care. Scrub-the-hub refers to cleaning catheter connector hubs and injection ports with alcohol for the recommended 15 seconds before accessing the central line, a catheter placed in a large vein to deliver medicine and liquids during hospitalization.
inVentiv Commercial, a division of inVentiv Health and the industry leader in outsourced sales teams to the pharmaceutical industry, announced today that it has been selected by international specialty pharmaceuticals company BTG International Inc to provide a sales team, as well as training and fulfillment services, for the company's CroFab® and DigiFab® products.
The number of Americans who report they have coronary heart disease – which includes heart attack and angina (chest pain) – continues to decline but rates vary widely from state to state and by race and ethnicity, according to a new report published today in the Morbidity and Mortality Weekly Report of the Centers for Disease Control and Prevention.
A CSIRO innovation for determining gene function quickly and with virtually 100 per cent efficiency has been granted a US patent clarifying its leadership position in the international gene silencing arena.
Decision Resources Group finds that the market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
› Verified 7 days ago
Entity Name | Erie County Medical Center Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528233616 PECOS PAC ID: 1456308907 Enrollment ID: O20050715000538 |
News Archive
Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period. A two-year study compared the use of disinfection caps to an intense scrub-the-hub intervention to standard care. Scrub-the-hub refers to cleaning catheter connector hubs and injection ports with alcohol for the recommended 15 seconds before accessing the central line, a catheter placed in a large vein to deliver medicine and liquids during hospitalization.
inVentiv Commercial, a division of inVentiv Health and the industry leader in outsourced sales teams to the pharmaceutical industry, announced today that it has been selected by international specialty pharmaceuticals company BTG International Inc to provide a sales team, as well as training and fulfillment services, for the company's CroFab® and DigiFab® products.
The number of Americans who report they have coronary heart disease – which includes heart attack and angina (chest pain) – continues to decline but rates vary widely from state to state and by race and ethnicity, according to a new report published today in the Morbidity and Mortality Weekly Report of the Centers for Disease Control and Prevention.
A CSIRO innovation for determining gene function quickly and with virtually 100 per cent efficiency has been granted a US patent clarifying its leadership position in the international gene silencing arena.
Decision Resources Group finds that the market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Naheed Alam, 617 Central Ave, Dunkirk, NY 14048-2529 Ph: (716) 366-1223 | Dr Naheed Alam, 617 Central Ave, Dunkirk, NY 14048-2529 Ph: (716) 366-1223 |
News Archive
Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period. A two-year study compared the use of disinfection caps to an intense scrub-the-hub intervention to standard care. Scrub-the-hub refers to cleaning catheter connector hubs and injection ports with alcohol for the recommended 15 seconds before accessing the central line, a catheter placed in a large vein to deliver medicine and liquids during hospitalization.
inVentiv Commercial, a division of inVentiv Health and the industry leader in outsourced sales teams to the pharmaceutical industry, announced today that it has been selected by international specialty pharmaceuticals company BTG International Inc to provide a sales team, as well as training and fulfillment services, for the company's CroFab® and DigiFab® products.
The number of Americans who report they have coronary heart disease – which includes heart attack and angina (chest pain) – continues to decline but rates vary widely from state to state and by race and ethnicity, according to a new report published today in the Morbidity and Mortality Weekly Report of the Centers for Disease Control and Prevention.
A CSIRO innovation for determining gene function quickly and with virtually 100 per cent efficiency has been granted a US patent clarifying its leadership position in the international gene silencing arena.
Decision Resources Group finds that the market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
› Verified 7 days ago
Michael Guilding Pita, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Chautauqua Medical Services, 504 Central Ave, Dunkirk, NY 14048 Phone: 716-366-9008 | |
Shakeel Ahmad, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 529 Central Ave, Suite 1, Dunkirk, NY 14048 Phone: 716-672-5420 | |
Dr. Ravi Jyot Singh Sahni, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3898 Vineyard Dr Ste 1, Dunkirk, NY 14048 Phone: 716-363-6960 | |
Avani Gayathri Kanneganti, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3898 Vineyard Dr Ste 1, Dunkirk, NY 14048 Phone: 716-363-6960 Fax: 716-203-7386 | |
Dr. Stephen Peter Smith, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3898 Vineyard Dr, Dunkirk, NY 14048 Phone: 716-363-1515 Fax: 716-363-7677 | |
Dr. Richard T Milazzo Jr., MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 515 Swan St, Dunkirk, NY 14048 Phone: 716-366-7331 Fax: 716-366-5228 |